An in-depth look at the International Programme Committee behind ICAHMS 2017 and their role in shaping medical science conferences
Discover how biapigenin, a potent flavonoid dimer, acts as a PPARγ modulator with significant anticancer properties through multiple molecular pathways.
Exploring the complex patent landscape of gene therapy, including CRISPR battles, manufacturing challenges, and breakthrough case studies in genetic medicine.
Exploring the synergistic effects of dual-target drugs in overcoming resistance in HER2-positive breast cancer treatment.
How open access consortia are transforming scientific publishing through collective action and billion-dollar negotiations.
Breakthrough research on zenocutuzumab, a bispecific antibody targeting NRG1 fusion-positive cancers, with results from the eNRGy trial showing promising outcomes across multiple tumor types.
Exploring the critical second genetic event that transforms BRCA susceptibility into breast cancer malignancy, with insights into mechanisms, clinical implications, and future research directions.
Discover how GO-2D reveals 2-dimensional functional modules in cells by mapping protein interactions to specific cellular locations and molecular functions.
Understanding immune-mediated toxicities in MDS patients treated with nivolumab and ipilimumab, including mechanisms, clinical patterns, and management strategies.
Discover how circular RNAs (circRNAs) are revolutionizing plant stress resistance and offering new hope for climate-resilient agriculture.